Thursday, October 22, 2020

Med, Biotech & Pharma

Emerging Growth Medical, Biotechnology and Pharmaceutical Companies

CytoDyn’s (CYDY) 100% Above Market Offering Stuns the Street

It is very rare for a stock to command a 100% premium in what amounts to a secondary offering unless there is...

STAT News’ Adam Feuerstein Uses Up His Nine Lives on CytoDyn (OTCQB: CYDY)

The feline has attacked CytoDyn Inc. (OTCMKTS: CYDY) nine times within the last 8 months in an...

Adam Feuerstein’s Fishing Expedition on CytoDyn (CYDY) Continues to Cast an Empty Net

Instead of reporting on the great advancements that CytoDyn Inc. (OTCMKTS: CYDY) has just announced the completion of  enrollment in its first randomized clinical...
Galectin Therapeutics, Inc. (NASDAQ: GALT) Most Feared Biotech Analyst Losing Relevance as Investor’s Crave Substance over Cyber Bullying

Galectin Therapeutics, Inc. (NASDAQ: GALT) Most Feared Biotech Analyst Losing Relevance as Investor’s Crave...

Miami, FL - September 21, 2018 (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

The Great CytoDyn (OTCQB: CYDY) Bear Raid Fails to Impress

Miami, FL – February 10, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

Dell (DELL) and Intel (INTC) Backing iAbra’s Virolens “20 Second” COVID-19 Test

US media hasn’t picked up on the linkage to DELL and INTC. The potential of a 20 second COVID-19 test is “priceless”. The existence of this test allows governments to loosen social distancing restrictions as they get used at schools, universities, airports, hospitals, sporting events...the list is endless!

Sorrento Therapeutics (NASDAQ: SRNE) COVID Cure – FACT or FICTION

Animal model use for target identification not as a predictor of efficacyCOVID-SHIELD or remdesivir would not be very effective against ARDSShorts cry...
Emerging Growth Biotechnology Company

Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) Extended Trial Shows Patients Can Avoid Total Knee Replacement

Miami, FL - March 30, 2018 (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...
Emerging Growth BioTech Company

Fake News Attack Against Ampio Pharmaceuticals (NASDAQ: AMPE) Starting to Unravel as Suitors Line...

Miami, FL - March 4, 2018 (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...
Emerging Growth Cancer research company

Galectin Therapeutics, Inc. (NASDAQ: GALT) A Potential $10 Billion Buyout

Miami, FL - September 12, 2018 7:55 PM (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of...

Latest News